Yinyan Xu
Yinyan Xu
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,†,
Ann Marie Weideman
Ann Marie Weideman
2
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
3
Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
2,3,†,
Maria Abad-Fernandez
Maria Abad-Fernandez
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,
Katie R Mollan
Katie R Mollan
3
Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
4
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States
3,4,
Sallay Kallon
Sallay Kallon
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,
Shahryar Samir
Shahryar Samir
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,
Joanna A Warren
Joanna A Warren
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,
Genevieve Clutton
Genevieve Clutton
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,
Nadia R Roan
Nadia R Roan
6
Department of Urology, University of California San Francisco, San Francisco, CA, United States
7
Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
6,7,
Adaora A Adimora
Adaora A Adimora
3
Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
4
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States
5
School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
3,4,5,
Nancie Archin
Nancie Archin
5
School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
5,
JoAnn Kuruc
JoAnn Kuruc
5
School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
5,
Cynthia Gay
Cynthia Gay
5
School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
5,
Michael G Hudgens
Michael G Hudgens
2
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
3
Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
2,3,
Nilu Goonetilleke
Nilu Goonetilleke
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
1,5,*
1
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
2
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
3
Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
4
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States
5
School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
6
Department of Urology, University of California San Francisco, San Francisco, CA, United States
7
Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Nilu Goonetilleke, nilu_goonetilleke@med.unc.edu
†These authors have contributed equally to this work
This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology
Received 2022 Nov 21; Accepted 2022 Nov 22; Collection date 2022.
Keywords: HIV, VIA, p24, JRCSF, ROC, CD8, CD4, T-cell
Copyright © 2023 Xu, Weideman, Abad-Fernandez, Mollan, Kallon, Samir, Warren, Clutton, Roan, Adimora, Archin, Kuruc, Gay, Hudgens and Goonetilleke
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.